This module uses fundamental data of Integral Diagnostics to approximate the value of its Beneish M Score. Integral Diagnostics M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integral Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Integral
Beneish M Score
Dividends Paid
Capital Expenditures
Total Cash From Operating Activities
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Net Borrowings
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Stock Based Compensation
Change To Inventory
Investments
Issuance Of Capital Stock
Total Assets
Total Current Liabilities
Total Stockholder Equity
Retained Earnings
Net Receivables
Total Liab
Common Stock
Short Long Term Debt Total
Other Current Liab
Net Debt
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Other Stockholder Equity
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Other Liab
Net Tangible Assets
Long Term Debt
Non Current Liabilities Total
Other Current Assets
Long Term Investments
Short Long Term Debt
Property Plant And Equipment Net
Current Deferred Revenue
Good Will
Common Stock Total Equity
Long Term Debt Total
Inventory
Property Plant And Equipment Gross
Intangible Assets
Property Plant Equipment
Short Term Investments
Capital Lease Obligations
Net Invested Capital
Net Working Capital
Capital Stock
Non Current Liabilities Other
Interest Expense
Total Revenue
Operating Income
Income Before Tax
Depreciation And Amortization
Selling General Administrative
Gross Profit
Other Operating Expenses
Ebit
Ebitda
Total Operating Expenses
Income Tax Expense
Net Income From Continuing Ops
Cost Of Revenue
Total Other Income Expense Net
Net Income Applicable To Common Shares
Tax Provision
Interest Income
Net Interest Income
Selling And Marketing Expenses
Reconciled Depreciation
Probability Of Bankruptcy
At this time, Integral Diagnostics' Net Debt is comparatively stable compared to the past year. Long Term Debt Total is likely to gain to about 420.7 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 190.3 M in 2024.
At this time, Integral Diagnostics' M Score is inapplicable. The earnings manipulation may begin if Integral Diagnostics' top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Integral Diagnostics executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Integral Diagnostics' earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
Integral Diagnostics Beneish M-Score Indicator Trends
The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Integral Diagnostics' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Integral Diagnostics Beneish M-Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Integral Diagnostics' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Integral Diagnostics in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Integral Diagnostics' degree of accounting gimmicks and manipulations.
M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.
Depreciation And Amortization
49.45 Million
At this time, Integral Diagnostics' Depreciation And Amortization is comparatively stable compared to the past year.
Integral Diagnostics Earnings Manipulation Drivers
Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Integral Diagnostics. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
The Macroaxis Fundamental Analysis modules help investors analyze Integral Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integral Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integral Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running Integral Diagnostics' price analysis, check to measure Integral Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integral Diagnostics is operating at the current time. Most of Integral Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integral Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integral Diagnostics' price. Additionally, you may evaluate how the addition of Integral Diagnostics to your portfolios can decrease your overall portfolio volatility.